6 reports

  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS PROGRESSION, 2016
  • 2.7.2 CHRONIC STAGE
  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS
  • 4.6 Disease Progression
  • Hepatitis
  • World
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Overall, it is believed that cigarette smoking causes approximately ##% of all cancer deaths in the US.

  • Hepatitis
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • RISK FACTORS AND COMORBIDITIES FOR HCC

Epidemiology BE DUE TO MEN BEING MORE LIKELY TO BE INFECTED WITH HBV AND HCV, TO CONSUME MORE ALCOHOL, TO SMOKE CIGARETTES, AND TO HAVE INCREASED IRON STORES (EL-SERAG AND RUDOLPH, 2007).

  • Hepatitis
  • Celsion Corporation
  • Eli Lilly & Co.
  • GlobalData's company
  • ThermoDox® group

THE IMPACT OF CHARACTERISTICS OF CIGARETTE SMOKING ON URINARY TRACT CANCER RISK: A META-ANALYSIS OF EPIDEMIOLOGIC STUDIES.

  • Hepatitis
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Japan Tobacco Inc (JT Group) is a tobacco company that manufactures and sells tobacco products, primarily cigarettes.

  • Hepatitis
  • HIV AIDS
  • United States
  • Corporate Finance
  • Gilead Sciences, Inc.